*ET NOW BROKERAGE RADAR*
CITI ON CROMPTON GREAVES CONSUMER
Maintain BUY , Target at `465/share
Healthy execution as company remains well positioned
Compton has executed well as evident from 2QFY21
Focus on new product launches and premiumisation
Raise target PE to 48x on healthy execution & prospects
CS ON INDIA IT
Accenture’s 1Q Rev was ahead of guided range
Pick-up in revenue growth and strong bookings reflect demand
Infosys and HCLT are our preferred picks in the sector.
Like Infosys given our expectations of its industry-leading revenue
Like HCLT due to its attractive valuation
CLSA ON L&T TECH
Upgrade L&T Tech to Outperform to Underperform , Target at 2020/share
Recent deal wins improve the long-term growth outlook
Deal traction improves growth visibility
Worst appears to be behind for ER&D services
Inelasticity of cost structure should now help
LTTS has underperformed the broader sector
CS ON HUL
Maintain Outperform , Target at `2500/share
Recovery likely to be slower than expected
HUL's growth likely to improve in Q3
Home care remains under pressure
Margin pressures likely to continue in near term: